Medicine The Day Immunotherapy Went Off-Patent In oncology, some milestones arrive with applause. Others arrive quietly. This year, one of the most important cancer drugs of the modern era begins to lose its monopoly. Nivolumab, one of the… By Amalya Sargsyan | Mar 18, 2026
